PRODIGE 86 (FFCD 2103 – GONO – ENGIC 02) – FOLFIRINOX SBA: Phase II randomized trial to evaluate mFOLFIRINOX and mFOLFOX for locally advanced or metastatic small bowel adenocarcinoma
ANNÉE
2024
AUTEURS
Aparicio T, Turpin A, Zaanan A, de la Fouchardière C, Le Malicot K, Lonardi S, Paul Modest D, Wilson R, Ballhausen A, Graham J, Guarssifi M, Svrcek M, Laurent Puig P, Manfredi S
CONGRÈS/REVUE
ESMO
ÉTUDE
Localisation
LIEN PUBLICATIONS ASSOCIÉES